SCHEMBL22239896

SCHEMBL22239896

C=C(NCC)c1ccc2c(n1)N(C(=C)Nc1cc(CCC(C)CC)ccn1)C1CCN2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22239941 0.92 — —
SCHEMBL22239801 0.80 — —
SCHEMBL22240332 0.79 CNR2 (0.31) —
SCHEMBL22239993 0.78 KDM4E (0.35) —
SCHEMBL22240215 0.77 NOS2 (0.32) —
SCHEMBL22240073 0.77 HTT (0.34) —
SCHEMBL22240057 0.76 MEN1 (0.34) —
SCHEMBL22240059 0.76 AXL (0.31) —
SCHEMBL22240267 0.75 MEN1 (0.34) —
SCHEMBL22240288 0.74 PHGDH (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3221317-B1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2020-07-22 — — EP disclosed
Send feedback